<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-05-20)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-05-20)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in funds</h3>
<p class='source-date'><em>Endpoints News • 2025-05-20</em></p>
<p>A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with the Murdoch Children's Research Institute in Australia. The California biotech, which has received</p>
<p><a href='https://endpts.com/retro-biosciences-inks-blood-disorder-deal-as-sam-altman-backed-biotech-seeks-1b-in-funds/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Prime Medicine Chops 25% of Workforce, Pivots Pipeline as CEO Quits</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>Prime’s effort to outlicense PM359 comes after it announced positive initial data following infusion of ex vivo prime edited autologous CD34+ hematopoietic stem cells (HSCs) in the first patient dosed in its ongoing Phase I/II trial. The post Prime Medicine Chops 25% of Workforce, Pivots Pipeline...</p>
<p><a href='https://www.genengnews.com/topics/genome-editing/prime-medicine-chops-25-of-workforce-pivots-pipeline-as-ceo-quits/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Why the Right Launch Strategy Can Get Biopharma from Clinical Breakthroughs to Commercial Blockbusters</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>Creating new medicines is an enormous scientific achievement, yet it only begins the battle for biopharmas. Multiple new product launches are fighting for space and recognition in an increasingly crowded and competitive marketplace. The post Why the Right Launch Strategy Can Get Biopharma from Cl...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/why-the-right-launch-strategy-can-get-biopharma-from-clinical-breakthroughs-to-commercial-blockbusters/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Biopharma is Mentally Ready, Yet Unprepared for AI Integration</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>Biopharma may be psychologically ready to accept AI, but they aren’t necessarily prepared for that integration. Cultural buy-in is still occurring and workers need to be trained to integrate effectively into their work. The post Biopharma is Mentally Ready, Yet Unprepared for AI Integration appea...</p>
<p><a href='https://www.genengnews.com/topics/artificial-intelligence/biopharma-is-mentally-ready-yet-unprepared-for-ai-integration/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Regeneron to Acquire 23andMe with Winning $256M Bid</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>The sale remains subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri, which has appointed an independent Consumer Privacy Ombudsman to examine the deal, assess its impact on consumers’ privacy, and report back to the court by June 10. The post Regeneron to Acquir...</p>
<p><a href='https://www.genengnews.com/topics/omics/regeneron-to-acquire-23andme-with-winning-256m-bid/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>10x Settles Bruker, Vizgen Patent Lawsuits</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial genomics fields. The post 10x Settles Bruker, Vizgen Patent Lawsuits appeared first on GEN - Genetic Engin...</p>
<p><a href='https://www.genengnews.com/topics/omics/10x-settles-bruker-vizgen-patent-lawsuits/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<p>No recent papers on Biotech & Microbiome Focus available today.</p>
<h3>Synthetic & Molecular Biology Papers</h3>
<div class='paper-item'>
<h4>Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity.</h4>
<p class='source-date'><em>Zhao Xiongfang, Lu Yuan, Zhang Xintong et al. | Microbial cell factories • 2025-05-19</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Chuangxinmycin (CM) is an old antibiotic from Actinoplanes tsinanensis CPCC, 200056, characterized by a dihydrothiopyrano[4,3,2-cd]indole scaffold and potent activity against Mycobacterium tuberculosis. Its congener norchuangxinmycin (NCM), which lacks antibacterial activity against v...</p>
<p><a href='https://doi.org/10.1186/s12934-025-02740-x' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancer.</h4>
<p class='source-date'><em>Jeong Eun-Jeong, Roh Yuna, Jung Eunsun et al. | Journal of biomedical science • 2025-05-19</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Gemcitabine (GEM) is used as a first-line therapy for patients diagnosed with any stage of pancreatic cancer (PC); however, patient survival is poor because of GEM resistance. Thus, new approaches to overcome GEM resistance in PC are urgently needed. Here, we aimed to establish an in ...</p>
<p><a href='https://doi.org/10.1186/s12929-025-01140-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.</h4>
<p class='source-date'><em>Swenson Hugo, Ittner Ella, Werner Lucas et al. | Journal of ovarian research • 2025-05-19</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Epithelial ovarian cancer (EOC) is a deadly and heterogenous disease comprising five major histotypes: clear cell carcinoma (CCC), endometrioid carcinoma (EC), low- and high-grade serous carcinoma (LGSC, HGSC), and mucinous carcinoma (MC). Despite this heterogeneity, EOC is often trea...</p>
<p><a href='https://doi.org/10.1186/s13048-025-01676-5' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A novel neutrophil extracellular traps related diagnostic signature for intracranial aneurysm.</h4>
<p class='source-date'><em>Zhang Xiangmao, Feng Hanhan, Li Zongxiang et al. | BMC neurology • 2025-05-19</em></p>
<p><strong>Abstract:</strong> Neutrophil extracellular traps (NETs) released by neutrophils can exacerbate inflammation, leading to rupture of intracranial aneurysms (IA). This study aims to explore potential NETs-related genes in IA. RNA sequencing data for IA were downloaded from the Gene Expression Omnibus database. NETs-r...</p>
<p><a href='https://doi.org/10.1186/s12883-025-04068-w' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>The progress and prospects of targeting the adenosine pathway in cancer immunotherapy.</h4>
<p class='source-date'><em>Yang Yuying, Zhu Lin, Xu Yantao et al. | Biomarker research • 2025-05-19</em></p>
<p><strong>Abstract:</strong> Despite the notable success of cancer immunotherapy, its effectiveness is often limited in a significant proportion of patients, highlighting the need to explore alternative tumor immune evasion mechanisms. Adenosine, a key metabolite accumulating in hypoxic tumor regions, has emerged as a promis...</p>
<p><a href='https://doi.org/10.1186/s40364-025-00784-0' target='_blank'>View Paper</a></p>
</div>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii.</h4>
<p class='source-date'><em>Sherif Mahmoud M, Abdelaziz Neveen A, Alshahrani Mohammad Y et al. | Scientific reports • 2025-05-17</em></p>
<p><strong>Abstract:</strong> The urgent threat of carbapenem-resistant Acinetobacter baumannii (CRAB) necessitates the development of new antimicrobial strategies. Bacteriophage (phage) therapy is one of the most promising alternative strategies that can be implemented to combat multidrug-resistant (MDR) bacterial infections...</p>
<p><a href='https://doi.org/10.1038/s41598-025-99788-x' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Phage-antibiotic synergy to combat multidrug resistant strains of Gram-negative ESKAPE pathogens.</h4>
<p class='source-date'><em>Morris Tinta Carmen, Reyneke Brandon, Khan Sehaam et al. | Scientific reports • 2025-05-18</em></p>
<p><strong>Abstract:</strong> Bacteriophage-antibiotic-synergy (PAS) was investigated to target Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii and Enterobacter cloacae. Whole genome sequencing indicated that bacteriophage KPW17 targeting K. pneumoniae, clustered with genus Webervirus, ECSR5 targeting E...</p>
<p><a href='https://doi.org/10.1038/s41598-025-01489-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Bacteriophages enhance the transformation of dissolved organic matter during vermicomposting of sludge.</h4>
<p class='source-date'><em>Zhu Licheng, Huang Kui, Bai Tiegen et al. | Bioresource technology • 2025-05-16</em></p>
<p><strong>Abstract:</strong> Vermicomposting is an eco-friendly technology for treating sewage sludge, however its efficiency in transforming biological material is often constrained. This study investigates the potential of bacteriophages to enhance the transformation of dissolved organic matter (DOM) during sludge vermicom...</p>
<p><a href='https://doi.org/10.1016/j.biortech.2025.132694' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Genomic characterization of the novel bacteriophage PfAn1 from Lake Baikal, infecting Pseudomonas fluorescens.</h4>
<p class='source-date'><em>Gorshkova Anna, Belykh Olga, Tikhonova Irina et al. | Archives of virology • 2025-05-16</em></p>
<p><strong>Abstract:</strong> We isolated a novel bacteriophage from Lake Baikal that infects Pseudomonas fluorescens. Transmission electron microscopy revealed that phage PfAn1 has a head with a diameter of 50 nm and a short tail. Its genome is 39,156 bp in length with a GC content of 57%. It is predicted to contain 53 open ...</p>
<p><a href='https://doi.org/10.1007/s00705-025-06315-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Optimal control strategies for mitigating antibiotic resistance: Integrating virus dynamics for enhanced intervention design.</h4>
<p class='source-date'><em>Dere Zainab, Cogan N G, Karamched Bhargav R | Mathematical biosciences • 2025-05-14</em></p>
<p><strong>Abstract:</strong> Given the global increase in antibiotic resistance, new effective strategies must be developed to treat bacteria that do not respond to first or second line antibiotics. One novel method uses bacterial phage therapy to control bacterial populations. Phage viruses replicate and infect bacterial ce...</p>
<p><a href='https://doi.org/10.1016/j.mbs.2025.109464' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<div class='paper-item'>
<h4>Intraspecies dynamics underlie the apparent stability of two important skin microbiome species.</h4>
<p class='source-date'><em>Baker Jacob S, Qu Evan, Mancuso Christopher P et al. | Cell host & microbe • 2025-05-14</em></p>
<p><strong>Abstract:</strong> Adult human facial skin microbiomes are remarkably similar at the species level, dominated by Cutibacterium acnes and Staphylococcus epidermidis, yet each person harbors a unique community of strains. Understanding how person-specific communities assemble is critical for designing microbiome-base...</p>
<p><a href='https://doi.org/10.1016/j.chom.2025.04.010' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Phenylacetaldehyde attenuates Cutibacterium acnes-induced inflammation in keratinocytes and monocytes.</h4>
<p class='source-date'><em>Lee Hyunbin, Kang Wesuk, Ha Yoojeong et al. | International immunopharmacology • 2025-05-17</em></p>
<p><strong>Abstract:</strong> Cutibacterium acnes (C. acnes)-induced inflammation is the key driver of acne vulgaris. C. acnes stimulates keratinocytes to secrete pro-inflammatory cytokines, subsequently triggering monocytes to produce additional cytokines. Although synthetic antibacterials, such as antibiotics, are commonly ...</p>
<p><a href='https://doi.org/10.1016/j.intimp.2025.114885' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Cutibacterium acnes of single locus sequence type clade C strains exhibit low susceptibility to benzoyl peroxide.</h4>
<p class='source-date'><em>Sakaguchi Natsumi, Seyama Shoji, Oba Ryota et al. | Journal of global antimicrobial resistance • 2025-05-15</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Cutibacterium acnes plays an important role in acne pathogenesis. Benzoyl peroxide (BPO) exhibits antimicrobial activity against C. acnes. We previously found that no clade C strains, as determined by single locus sequence typing (SLST), were found before the introduction of BPO in Ja...</p>
<p><a href='https://doi.org/10.1016/j.jgar.2025.04.030' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Unveiling strain-level dynamics in the human skin microbiome.</h4>
<p class='source-date'><em>Li Zhiming, Xia Jingjing, Wang Jiucun | Cell host & microbe • 2025-05-14</em></p>
<p><strong>Abstract:</strong> Species-level uniformity on the skin surface masks substantial strain-level diversity modulated by ecological dynamics. In this issue of Cell Host & Microbe, Jacob et al. uncover dynamic intraspecies behaviors, revealing different patterns of colonization and persistence for two important skin co...</p>
<p><a href='https://doi.org/10.1016/j.chom.2025.03.014' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Non-synonymous ERG11 mutations in </h4>
<p class='source-date'><em>Leong Cheryl, Chua Wisely, Chong Cheng-Shoong et al. | Microbiology spectrum • 2025-05-15</em></p>
<p><strong>Abstract:</strong> UNLABELLED:  IMPORTANCE:</p>
<p><a href='https://doi.org/10.1128/spectrum.00007-25' target='_blank'>View Paper</a></p>
</div>
<hr>
<p><em>Report generated on 2025-05-20</em></p>
</div>
</body>
</html>